Zync is now Believeco

We’re excited to announce that Zync has joined together with several renowned agencies to become Believeco, one of Canada’s largest independent agencies. This will expand the business we've built on a larger scale, so we can continue to help you with every element of brand and digital, and now offer a wider range of advertising and media.

Brought together by Arlene Dickinson – one of Canada’s most recognized and respected business leaders— Zync joins the other original agencies Venture Play, Revolve and Brightworks as Believeco.

Along with Argyle, one of North America’s most respected engagement, communications and reputation advisory agencies and Castlemain, a leading Indigenous advisory firm, we are collectively Believeco:Partners. Believeco:Partners owns, operates and builds the foremost marketing, communications and engagement agencies in North America. Together, we offer clients the talents of more than 300 marketing and communications professionals across North America.

Together, we’ll help clients navigate the incredible pace of change—providing solutions and a culture that is good for our clients, their customers and stakeholders, our people, and our local, national and global community.

Find out more! believecopartners.com

Brad Breininger & Marko Zonta

Zync - Journal | Moving into our new digs.

Zync’s new office—130 Queens Quay East, Toronto.

Moving into our new digs.

We are super excited to move into our new office space at 130 Queens Quay East. The space is a perfect combination of an open space ideal for teamwork, and break-out spaces and meeting rooms for brainstorming and meetings.

Related articles

News
Zync wins Webby Award for chrishadfield.ca
empty
We are proud and honoured to be working with Chris Hadfield's team to turn an idea into a winning reality. It's simply out of this world.
Read more
News
We wanted to help.
empty
At the beginning of the pandemic, we knew that we could help by offering our expertise to an organization that was helping in the fight against Covid.
Read more